Cocaine intoxication - Symptoms, Causes, Treatment & Prevention

Overview

Cocaine intoxication refers to the acute physiological and psychological effects that occur after using cocaine in amounts that exceed an individual’s tolerance. Cocaine is a powerful central‑ nervous system stimulant derived from the leaves of the Erythroxylon coca plant. It is most commonly encountered as a white powder (hydrochloride salt) or as “crack” (the free‑base form that is smoked).

Who it affects: While anyone can use cocaine, the highest prevalence is among adolescents and young adults aged 18–35 years. In the United States, the 2022 National Survey on Drug Use and Health estimated that ~5.2 million people (≈1.9 % of the population) reported past‑year cocaine use, with higher rates among males, non‑Hispanic whites, and individuals with co‑occurring substance‑use disorders.

Global prevalence: The United Nations World Drug Report 2023 noted that about 19 million people worldwide used cocaine in the past year, making it the second‑most‑used illicit drug after cannabis. Acute intoxication accounts for a substantial proportion of emergency‑department (ED) visits related to illicit drugs.

Symptoms

Symptoms can appear within seconds to minutes after use (especially when smoked or injected) and usually peak within 15–30 minutes. The clinical picture is highly variable, reflecting dose, route, individual tolerance, and presence of other substances.

Central nervous system (CNS)

• Euphoria, confidence, increased sociability – “high” feeling.
• Agitation, restlessness, irritability – may progress to anxiety or panic.
• Paranoia, hallucinations (visual, auditory) – more common with high doses or chronic use.
• Seizures – generalized tonic‑clonic seizures in 1–2 % of acute overdoses.
• Headache, dizziness, confusion.
• Stroke symptoms – sudden weakness, speech difficulty, visual loss (due to vasospasm or embolism).

Cardiovascular

• tachycardia (heart rate often >100 bpm).
• Hypertension – systolic >140 mmHg or diastolic >90 mmHg.
• Chest pain – may indicate myocardial ischemia or infarction even in young, otherwise healthy people.
• Arrhythmias – atrial fibrillation, ventricular tachycardia.
• Cardiac arrest – rare but documented.

Respiratory

• Hyperventilation or rapid breathing.
• Bronchospasm (especially with smoked crack).
• Pulmonary edema – usually “non‑cardiogenic” and linked to severe intoxication.

Gastrointestinal

• Nausea and vomiting.
• Abdominal pain (sometimes due to mesenteric ischemia).

Dermatologic & Other

• Pupillary dilation (mydriasis).
• Profuse sweating.
• Skin “puckering” or “track marks” if injected.
• Hyperthermia – body temperature >38.5 °C, especially with binge use.

Causes and Risk Factors

Primary cause: Ingestion of cocaine, whether as powder (snorted, oral, or injected) or as crack (smoked). The drug blocks the reuptake of dopamine, norepinephrine, and serotonin, causing a surge of neurotransmitters that drives the stimulant effects.

Risk factors for intoxication

• High dose or binge use – “speedball” (cocaine + heroin) increases risk.
• Route of administration – smoking or intravenous injection leads to rapid peak levels.
• Polysubstance use – alcohol, benzodiazepines, or amphetamines potentiate toxicity.
• Pre‑existing cardiovascular disease – hypertension, coronary artery disease.
• Psychiatric comorbidity – anxiety disorders, schizophrenia.
• Genetic variability in cytochrome P450 enzymes (CYP3A4) affecting metabolism.
• Pregnancy – maternal use increases risk of fetal exposure and complications.

Diagnosis

Diagnosis is primarily clinical, supported by laboratory testing when available.

Clinical assessment

• History of recent cocaine use (self‑report, bystander, or collateral information).
• Focused physical exam looking for tachycardia, hypertension, dilated pupils, hyperthermia, and neurologic changes.
• Screen for co‑ingestants (alcohol, opioids, amphetamines) because mixed intoxication alters management.

Laboratory & toxicology tests

• Urine immunoassay – detects benzoylecgonine (major metabolite) with a detection window of 2–4 days for occasional use, longer for chronic users.
• Serum or plasma cocaine level – rarely needed in routine care; useful in forensic or research settings.
• Blood gas analysis – assesses for metabolic acidosis, hypoxia.
• Cardiac enzymes (troponin I/T) – evaluate for myocardial injury.
• Electrocardiogram (ECG) – looks for ST‑segment changes, QT prolongation, arrhythmias.
• Imaging – CT/MRI of brain if stroke or hemorrhage suspected; chest X‑ray for pulmonary edema.

Treatment Options

Management focuses on stabilizing vital signs, preventing complications, and supporting the patient while the drug clears (cocaine’s half‑life is about 1 hour). Most cases resolve within 4–6 hours with supportive care.

Emergency stabilization

1. Airway, Breathing, Circulation (ABCs) – ensure oxygenation; administer supplemental O₂ if SpO₂ <94 %.
2. Control agitation – benzodiazepines (e.g., lorazepam 1‑2 mg IV, repeat q5‑10 min) are first‑line for anxiety, tremor, or seizures.
3. Manage hypertension & tachycardia – short‑acting agents such as IV nitroglycerin, nicardipine, or labetalol (avoid pure β‑blockers alone because of unopposed α‑adrenergic stimulation).
4. Seizure control – benzodiazepines followed by phenobarbital if seizures persist.
5. Chest pain – treat as possible acute coronary syndrome per ACC/AHA guidelines (aspirin, nitroglycerin, cardiac monitoring).

Pharmacologic adjuncts

• Alpha‑adrenergic antagonists (phentolamine) may be used for severe hypertension refractory to standard agents.
• Cooling measures for hyperthermia – evaporative cooling, antipyretics are less effective because the fever is neurogenic.
• Antipsychotics (e.g., haloperidol) only after benzodiazepines have failed and if severe psychosis persists.

Detoxification & long‑term care

• Psychosocial interventions – Cognitive‑behavioral therapy (CBT), contingency management, and 12‑step programs have strong evidence (see NIH NIAAA).
• Medication‑assisted treatment (MAT) – No FDA‑approved pharmacotherapy for cocaine use disorder, but off‑label options such as disulfiram, topiramate, or modafinil may reduce cravings in selected patients (Cochrane Review 2022).
• Supportive resources – referral to addiction specialists, community support groups, and primary-care follow‑up.

Living with Cocaine Intoxication

For individuals who have experienced an acute intoxication episode, the focus shifts to recovery and relapse prevention.

• Medical follow‑up – Schedule a primary‑care visit within 1‑2 weeks to assess cardiovascular status (blood pressure, ECG).
• Stress management – Use mindfulness, exercise, and adequate sleep to lower the urge to use.
• Avoid triggers – Identify people, places, or emotions linked to past use and develop coping strategies.
• Medication review – Discuss any prescribed drugs that may interact with cocaine or increase cravings.
• Nutrition & hydration – Replenish electrolytes after binge episodes; a balanced diet supports brain recovery.
• Legal & social support – Seek assistance for housing, employment, or legal issues that may exacerbate stress.

Prevention

Preventing cocaine intoxication involves both public‑health measures and personal choices.

• Education – School‑based programs that convey the acute cardiovascular risks (e.g., a 1‑in‑5 chance of an ED visit after first use, CDC 2023).
• Screening – Routine substance‑use screening in primary‑care and emergency settings using validated tools (e.g., ASSIST, SBIRT).
• Community outreach – Needle‑exchange programs and safe‑use counseling reduce harm among people who inject.
• Policy – Enforcement of drug‑trafficking laws while simultaneously expanding access to treatment (see WHO “Global Action Plan on Substance Use” 2022).
• Personal strategies – Set clear limits, keep emergency contacts handy, and never combine cocaine with alcohol or opioids.

Complications

If intoxication is not promptly recognized and treated, a range of severe complications can arise:

• Cardiovascular – Myocardial infarction, arrhythmias, aortic dissection, sudden cardiac death.
• Neurologic – Ischemic or hemorrhagic stroke, seizures, intracerebral hemorrhage.
• Respiratory – Acute pulmonary edema, pneumothorax (from severe coughing).
• Renal – Rhabdomyolysis leading to acute kidney injury.
• Infectious – Endocarditis (particularly with injection), HIV/Hepatitis C from needle sharing.
• Psychiatric – Persistent psychosis, severe depression, increased suicide risk.
• Pregnancy‑related – Placental abruption, fetal growth restriction, neonatal withdrawal.

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. “Cocaine intoxication.” Updated 2023. mayoclinic.org
2. CDC. “Drug Overdose Deaths.” 2023. cdc.gov
3. National Institute on Drug Abuse. “Cocaine.” 2022. drugabuse.gov
4. World Health Organization. “Global Action Plan on Alcohol and Drug Use.” 2022.
5. Cochrane Database of Systematic Reviews. “Pharmacological interventions for cocaine dependence.” 2022.
6. American College of Cardiology/American Heart Association. “Guideline for the Management of Acute Coronary Syndromes.” 2021.
7. UNODC World Drug Report 2023.